Cargando…
Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis
BACKGROUND: Myelin/oligodendrocyte glycoprotein (MOG) is a putative autoantigen in multiple sclerosis (MS). Establishing the pathological relevance and validity of anti-MOG antibodies as biomarkers has yielded conflicting reports mainly due to different MOG isoforms used in different studies. Becaus...
Autores principales: | Menge, Til, Lalive, Patrice H, von Büdingen, H -Christian, Genain , Claude P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238300/ https://www.ncbi.nlm.nih.gov/pubmed/22093619 http://dx.doi.org/10.1186/1742-2094-8-161 |
Ejemplares similares
-
Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease according to their epitopes
por: Seok, Jin Myoung, et al.
Publicado: (2023) -
The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway
por: Lerch, Magdalena, et al.
Publicado: (2023) -
Antibody-mediated biorecognition of myelin oligodendrocyte glycoprotein: computational evidence of demyelination-related epitopes
por: Ierich, Jéssica Cristiane Magalhães, et al.
Publicado: (2019) -
The myelin oligodendrocyte glycoprotein directly binds nerve growth
factor to modulate central axon circuitry
por: von Büdingen, H.-Christian, et al.
Publicado: (2015) -
Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)